NR546 CEA COMPREHENSIVE EXAM -
ADVANCED PSYCHOPHARMACOLOGY
FOR THE PMHNP - CHAMBERLAIN
UNIVERSITY
100 practice questions with answer rationales
COURSE NR546 CEA Comprehensive Exam - Advanced Psychopharmacology For The...
QUESTIONS 100
PREPARED August 2026
,NR546 CEA Comprehensive Exam - Advanced...
Exam Overview
This academic exam resource gives Nursing School a focused 100-question practice set for CEA
Comprehensive - Advanced Psychopharmacology For The PMHNP - Chamberlain Univ. The material
is written to support careful review, practical reasoning, and steady preparation without promotional
claims or repeated title wording. Questions use clear professional language, credible answer choices,
and concise rationales that help students understand why one option is best. The document provides
high-quality academic material for independent revision, classroom reinforcement, and identifying
knowledge gaps before assessments. Students should pair it with course notes, textbooks, instructor
guidance, and current academic standards for the strongest preparation. Each.
Question 1: What does the term pharmacokinetics describe in psychopharmacology?
A. How a drug produces its clinical effect at receptor sites
B. How the body absorbs, distributes, metabolizes, and eliminates a drug
C. The combined use of two medications to increase symptom control
D. The placebo response seen before drug exposure
Answer: B
Rationale: Pharmacokinetics refers to what the body does to the medication: absorption, distribution,
metabolism, and excretion. Option A describes pharmacodynamics, which is a common confusion.
Question 2: Which statement best describes a black box warning on a psychiatric
medication?
A. It is a suggestion that the drug should only be used after two failed trials
B. It means the drug is contraindicated in all patients under age 25
C. It highlights a serious risk that requires close monitoring and patient education
D. It indicates the medication has no known long-term adverse effects
Answer: C
Rationale: A black box warning alerts prescribers to a serious or potentially life-threatening risk that
must be considered in prescribing and monitoring. It does not mean the drug is banned, and it is not
proof of safety.
Question 3: A medication that blocks dopamine D2 receptors is most directly associated
with which therapeutic effect in psychiatry?
A. Prevention of serotonin syndrome
B. Immediate reversal of benzodiazepine intoxication
C. Treatment of acute nicotine withdrawal
D. Reduction of psychotic symptoms such as hallucinations and delusions
Answer: D
Page 1 of 29
, NR546 CEA Comprehensive Exam - Advanced...
Rationale: D2 receptor blockade is the core mechanism of antipsychotic benefit for positive
psychotic symptoms. The other choices involve different drug classes and mechanisms, so they are
tempting but incorrect.
Question 4: A client taking lithium reports new coarse tremor, diarrhea, and unsteady gait.
What concern should the PMHNP consider first?
A. Therapeutic response to treatment
B. Tardive dyskinesia
C. Serotonin discontinuation syndrome
D. Lithium toxicity
Answer: D
Rationale: Coarse tremor, GI symptoms, and gait instability are classic warning signs of lithium
toxicity. Tardive dyskinesia is linked to dopamine-blocking agents, not lithium.
Question 5: A black box warning on antidepressants in younger patients primarily
emphasizes the need to monitor for what?
A. Weight gain
B. Insomnia
C. Emergent suicidality
D. Hair loss
Answer: C
Rationale: The warning highlights increased risk of suicidal thoughts and behaviors early in
treatment.
Question 6: Which antidepressant class primarily increases both norepinephrine and
serotonin by inhibiting their reuptake?
A. Selective serotonin reuptake inhibitors (SSRIs)
B. Tricyclic antidepressants used only for insomnia
C. Monoamine oxidase inhibitors (MAOIs)
D. Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Answer: D
Rationale: SNRIs inhibit reuptake of both serotonin and norepinephrine. SSRIs primarily affect
serotonin alone, and MAOIs work by blocking enzymatic breakdown rather than reuptake.
Question 7: A patient with obesity and type 2 diabetes asks for an antipsychotic with the
lowest typical risk of weight gain. Which agent is generally most weight-neutral?
A. Olanzapine
B. Clozapine
Page 2 of 29
ADVANCED PSYCHOPHARMACOLOGY
FOR THE PMHNP - CHAMBERLAIN
UNIVERSITY
100 practice questions with answer rationales
COURSE NR546 CEA Comprehensive Exam - Advanced Psychopharmacology For The...
QUESTIONS 100
PREPARED August 2026
,NR546 CEA Comprehensive Exam - Advanced...
Exam Overview
This academic exam resource gives Nursing School a focused 100-question practice set for CEA
Comprehensive - Advanced Psychopharmacology For The PMHNP - Chamberlain Univ. The material
is written to support careful review, practical reasoning, and steady preparation without promotional
claims or repeated title wording. Questions use clear professional language, credible answer choices,
and concise rationales that help students understand why one option is best. The document provides
high-quality academic material for independent revision, classroom reinforcement, and identifying
knowledge gaps before assessments. Students should pair it with course notes, textbooks, instructor
guidance, and current academic standards for the strongest preparation. Each.
Question 1: What does the term pharmacokinetics describe in psychopharmacology?
A. How a drug produces its clinical effect at receptor sites
B. How the body absorbs, distributes, metabolizes, and eliminates a drug
C. The combined use of two medications to increase symptom control
D. The placebo response seen before drug exposure
Answer: B
Rationale: Pharmacokinetics refers to what the body does to the medication: absorption, distribution,
metabolism, and excretion. Option A describes pharmacodynamics, which is a common confusion.
Question 2: Which statement best describes a black box warning on a psychiatric
medication?
A. It is a suggestion that the drug should only be used after two failed trials
B. It means the drug is contraindicated in all patients under age 25
C. It highlights a serious risk that requires close monitoring and patient education
D. It indicates the medication has no known long-term adverse effects
Answer: C
Rationale: A black box warning alerts prescribers to a serious or potentially life-threatening risk that
must be considered in prescribing and monitoring. It does not mean the drug is banned, and it is not
proof of safety.
Question 3: A medication that blocks dopamine D2 receptors is most directly associated
with which therapeutic effect in psychiatry?
A. Prevention of serotonin syndrome
B. Immediate reversal of benzodiazepine intoxication
C. Treatment of acute nicotine withdrawal
D. Reduction of psychotic symptoms such as hallucinations and delusions
Answer: D
Page 1 of 29
, NR546 CEA Comprehensive Exam - Advanced...
Rationale: D2 receptor blockade is the core mechanism of antipsychotic benefit for positive
psychotic symptoms. The other choices involve different drug classes and mechanisms, so they are
tempting but incorrect.
Question 4: A client taking lithium reports new coarse tremor, diarrhea, and unsteady gait.
What concern should the PMHNP consider first?
A. Therapeutic response to treatment
B. Tardive dyskinesia
C. Serotonin discontinuation syndrome
D. Lithium toxicity
Answer: D
Rationale: Coarse tremor, GI symptoms, and gait instability are classic warning signs of lithium
toxicity. Tardive dyskinesia is linked to dopamine-blocking agents, not lithium.
Question 5: A black box warning on antidepressants in younger patients primarily
emphasizes the need to monitor for what?
A. Weight gain
B. Insomnia
C. Emergent suicidality
D. Hair loss
Answer: C
Rationale: The warning highlights increased risk of suicidal thoughts and behaviors early in
treatment.
Question 6: Which antidepressant class primarily increases both norepinephrine and
serotonin by inhibiting their reuptake?
A. Selective serotonin reuptake inhibitors (SSRIs)
B. Tricyclic antidepressants used only for insomnia
C. Monoamine oxidase inhibitors (MAOIs)
D. Serotonin-norepinephrine reuptake inhibitors (SNRIs)
Answer: D
Rationale: SNRIs inhibit reuptake of both serotonin and norepinephrine. SSRIs primarily affect
serotonin alone, and MAOIs work by blocking enzymatic breakdown rather than reuptake.
Question 7: A patient with obesity and type 2 diabetes asks for an antipsychotic with the
lowest typical risk of weight gain. Which agent is generally most weight-neutral?
A. Olanzapine
B. Clozapine
Page 2 of 29
